Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients
Not Applicable
- Conditions
- type 2 diabetic patients with hypertension
- Registration Number
- JPRN-UMIN000005064
- Lead Sponsor
- Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with HbA1c higher than 8.4% were excluded from the study. In addition, patients with severe renal or hepatic disease, overt cardiovascular disease, and malignancy were excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the effects on blood pressure (BP) and various metabolic parameters.
- Secondary Outcome Measures
Name Time Method